Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-091440

Chief Medical Officer sold 6,461 shares at $14.58 ($94,205)

From the SEC's structured data for this filing

Trades in this filing

Bedrosian Camille L · Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-03-02 Sale : show line 1 in the form −6,461 $14.58 $94,205 169,295 D
Open-market sales · 6,461 sh · avg $14.58 · $94,205
Loading xslF345X05/ownership.xml…